StockWatch
·

Research Reports

16 Aug 2026
EMCUREEmcure Pharmaceuticals Ltd

The 22.8% beat nobody's betting on

revenue beat · domestic organic soft · guidance caution

Result verdictFollow-upQ1 FY276 minPharma & Healthcare
EMCUREEmcure Pharmaceuticals Ltd

Revenue beat masked by soft domestic organic and maintained cautious guidance

revenue beat · domestic organic soft · ARV ramp

TranscriptDeep diveQ1 FY276 minPharma & Healthcare
LUPINLUPIN LTD.

Beat growth, margin pressure starts

earnings · growth · margin compression

Result verdictFollow-upQ1 FY276 minPharma & Healthcare
LUPINLUPIN LTD.

Record Q1 growth masks margin compression ahead

US competition pressure · pipeline execution · margin normalization

TranscriptDeep diveQ1 FY276 minPharma & Healthcare
DIVISLABDIVI'S LABORATORIES LTD.

₹902 Crore Profit Masks Flat Generic Volumes and Margin Lumpiness

CDMO · Custom Synthesis · capex ramp

Result verdictFollow-upQ1 FY276 minPharma & Healthcare
DIVISLABDIVI'S LABORATORIES LTD.

27.8% growth masks generic stagnation; capex ramp ahead

custom synthesis ramp · validation batches · regulatory dependency

TranscriptDeep diveQ1 FY276 minPharma & Healthcare
MANIPALHOSManipal Health Enterprises Ltd

Can Manipal Health Sustain Q1 Momentum with Bed Expansion & Occupancy Gains?

bed capacity expansion · occupancy rates · ARPOB trajectory

Result previewQ1 FY273 minPharma & Healthcare
15 Aug 2026
UNIMECHSTLTECH+14

16 results out of 4,000: the rarest earnings of this season, and what happened next

Q1 FY27 · results season · earnings

ResearchDeep dive6 minIndustrials & Infra
14 Aug 2026
DCALDishman Carbogen Amcis Ltd

Dishman Carbogen swings to Rs57.9 Cr consolidated loss as margins crash to 8.9% YoY

cdmo · pharma api · margin compression

ResultsQ1 FY273 minPharma & Healthcare
GUFICBIOGUFIC BIOSCIENCES LTD.

Gufic Biosciences Q1FY27: consolidated PAT +71% YoY on margin gains, revenue +16.6%

pharmaceuticals · margin expansion · yoy growth

ResultsQ1 FY273 minPharma & Healthcare
GKSLGujarat Kidney and Super Speciality Ltd

Gujarat Kidney Q1: consolidated PAT flat YoY despite 125% revenue surge as margins halve

hospital chain · margin compression · consolidated results

ResultsQ1 FY273 minPharma & Healthcare
RUBICONRubicon Research Ltd

Rubicon Q1FY27: consolidated PAT up 96% YoY to ₹84.8 Cr, margin beats 22-23% guidance

pharmaceuticals · cdmo · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
METROPOLISMetropolis Healthcare Ltd

When Smart Money Exits in Sync: Metropolis's Coordinated Institutional & Promoter Sell-Off

insider selling · institutional exit · shareholding pattern

ResearchDeep dive7 minPharma & Healthcare
NATCOPHARMNATCO PHARMA LTD.

Natco Q1 FY27: consolidated PAT falls 57% YoY to ₹206.5 Cr on Lenalidomide exit

lenalidomide · margin compression · yoy decline

ResultsQ1 FY273 minPharma & Healthcare
ALKEMAlkem Laboratories Ltd

Alkem Q1FY27: consolidated PAT down 22% YoY on tax-regime reset, PBT nearly flat

pharma · tax regime change · effective tax rate

ResultsQ1 FY273 minPharma & Healthcare
KMCSHILKMC SPECIALITY HOSPITALS (INDIA) LTD.

KMC Speciality Hospitals Q1 FY27: PAT surges 120% YoY as margins expand, revenue +38%

hospital · healthcare services · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
THYROCAREThyrocare Technologies Ltd

When the Promoter Steps Back—Thyrocare's ₹977 Crore Exit Decoded

promoter exit · shareholding · deleveraging

ResearchCatalyst check6 minPharma & Healthcare
13 Aug 2026
GAUDIUMIVFGaudium IVF and Women Health Ltd

Gaudium IVF Q1 PAT falls 42% YoY to Rs1.78 Cr on expansion spend; revenue up 9%

ivf · fertility care · margin compression

ResultsQ1 FY273 minPharma & Healthcare
MEDICOMedico Remedies Ltd

Medico Remedies Q1FY27: revenue +81% YoY, PAT +38% as margins compress sharply

pharmaceutical formulations · margin compression · export sales decline

ResultsQ1 FY273 minPharma & Healthcare
PANACEABIOPANACEA BIOTEC LTD.

Panacea Biotec Q1 FY27: consolidated PAT down 44% YoY on smaller one-off; core swings to profit

vaccines · formulations · margin compression

ResultsQ1 FY273 minPharma & Healthcare
SUPRIYASupriya Lifescience Ltd

Supriya Lifescience Q1FY27: PAT down 31% YoY on margin squeeze despite 31% revenue growth

pharmaceutical api · margin compression · raw material cost inflation

ResultsQ1 FY273 minPharma & Healthcare
RAJNISHRajnish Wellness Ltd

Rajnish Wellness Q1 FY27: PAT falls 43% YoY, margins near-zero despite revenue surge

pharma distribution · margin compression · low base growth

ResultsQ1 FY273 minPharma & Healthcare
IPCALABIPCA LABORATORIES LTD.

IPCA Q1 FY27: consolidated PAT +72% YoY to ₹402 Cr as margins expand, revenue +21%

pharmaceuticals · margin expansion · export growth

ResultsQ1 FY273 minPharma & Healthcare
LINCOLNLINCOLN PHARMACEUTICALS LTD.

Lincoln Pharma Q1FY27: consolidated PAT up 31% YoY to ₹36.2 Cr as revenue rises 15%

pharmaceuticals · export expansion · other income growth

ResultsQ1 FY273 minPharma & Healthcare
12 Aug 2026
APOLLOHOSPAPOLLO HOSPITALS ENTERPRISE LTD.

Apollo Hospitals Q1 FY27: consolidated PAT +38% YoY to Rs.610 Cr as revenue grows 21%, margins expand

healthcare services · margin expansion · pharmacy distribution

ResultsQ1 FY273 minPharma & Healthcare
BLISSGVSBLISS GVS PHARMA LTD.

Bliss GVS Q1FY27: revenue +38% YoY, opex efficiency lifts OPM to 26.8%; PAT +16% YoY

margin expansion · material cost efficiency · open offer

ResultsQ1 FY273 minPharma & Healthcare
SHALBYShalby Ltd

Shalby Q1FY27: consolidated PAT +37% YoY on lower tax, PBT falls 13%, margins compress

hospital services · medtech segment losses · margin compression

ResultsQ1 FY273 minPharma & Healthcare
NGLFINENGL FINE-CHEM LTD.

NGL Fine-Chem Q1 FY27: PAT nearly doubles YoY to ₹18.4 Cr, margins expand to 16.7%

pharma intermediates · margin expansion · opm expansion

ResultsQ1 FY273 minPharma & Healthcare
NATCAPSUQNATURAL CAPSULES LTD.

Natural Capsules Q1FY27: consolidated loss ₹5.7 Cr on API drag; standalone PAT +60% YoY

gelatin capsules · hpmc capsules · api business

ResultsQ1 FY273 minPharma & Healthcare
SGRLShree Ganesh Remedies Ltd

Shree Ganesh Remedies Q1FY27: consolidated PAT -67% YoY, revenue -42% ahead of Block-7 ramp

api intermediates · specialty chemicals · margin compression

ResultsQ1 FY273 minPharma & Healthcare